Xplico CapTable

Keeping track of “who owns what” in multilayered ownership structures of life science companies and “what happens if” in various investment and exit scenarios is a time-consuming task for companies managements. Different types of shares, outstanding warrants, individual preference rights, interest on investments, anti-dilution protection terms and other conditions are among variants that can complicate the structure.

Xplico CapTable is a standardized Excel-based tool which is built and tailored to facilitate syncing up, updating and keeping accurate track of multiple ownership and exit scenarios while it is still easy to work with.

  • What is the investors’ return on their investment? When will shares and warrants be ‘In The Money’?
  • What are the consequences for existing shareholders of a new funding round?
  • How will new warrants dilute existing shareholders value?
  • Analyzing various exit, vesting schedule, termination, transfer and other “what happens if” scenarios
Based on more than 10 years of experience and supporting 100 life science companies with powerful valuation analysis, Xplico has now built an advanced cap table tool tailored to simplify complex ownership structures of life science industry

We offer

  • Highly specialised infographics, automatically generated and easy to understand, present and share.
  • A proven concept that has been successfully challenged by leading biotech companies and validated by acknowledged accountant firms.
  • A ready to go model and easy to use, flexible tool tailored for your requirements, your specific rules, Shareholder Register and Articles Of Association.
  • Support and backup from our experienced consultants who hand over the tool to you and train and support you to do the analysis on your own.

Our customers say

Very helpful in modelling multiple scenarios for communicating to shareholders. Top-notch support!
John Freshley, CEO, ONL Therapeutics
Tailored to our specific requirements for a new warrant scheme and preparing for a successful IPO. Highly recommend it to biotech companies with shareholder preference rights. Saves time and facilitates discussions with investors.
Anders Vadsholt, CFO, Orphazyme ApS

Benefits and full support when

  • Planning new funding rounds and warrants – it is easy to see the effect on the split between investors and share classes quickly and simultaneously
  • Preparing presentations for investors and the board- high quality outputs like graphs and analysis are automatically generated
  • Conducting funding round discussions – you are able to support your investors showing the split of value created over time and tell the consequences of a new share class for existing investors
  • You need backup, when lacking resources – we can step in and support you to smoothly track the transitions and valuations
  • You would like to minimize errors and time spent to build your own model and formulas

Get started

Contact us if you are interested in learning more. We will introduce the model and our services to you and learn about your requirements.
We provide a cap table model tailored for your company, hand it over to you and give you the training to use and maintain the tool on your own, while supporting your analysis all the way when needed – all depending on your preferences. In all cases, our mission is to give you the advantage.

Contact Us

Finn Nikolajsen
Tel: +45 51327703
Uffe Boesen
Tel: +45 61716935
Xplico is the market leader in life science valuation. Established in 2005, we have become the valuation partner of choice in EU and US, supporting more than 100 biotech and pharma companies. For more information about Xplico and our clients please refer to our website www.xplico.com

Key output features of Xplico CapTable


Traditional Waterfall at an exit scenario. For all shares, a single investor or group investors

Investment vs Company Value

View investment vs proceeds for each investor

Number of shares per investor

Number of shares after dilution and warrants

Proceeds per investor

The composition of proceeds between investors

Share value

The value of each class share vs company value

Proceeds per share class

When do share classes get in the money

Investment vs proceeds

The investment versus proceeds per investor

Proceeds per investor

Investors return vs company value for all shares

More about Xplico

Xplico CapTable has been built following huge success of Xplico Evaluator, a highly specialized and flexible valuation tool with integrated risk assessment and powerful analysis features for the life
science industry. Xplico Evaluator is built on our long experience with real needs of life science industry. The tool has been improved and fine-tuned over the last 10 years with valuable inputs from
our clients and is today used by more than 100 biotech and pharma companies on a day to day basis for partnering, project and company valuation and portfolio management. Xplico CapTable is built on the same blocks and principles as Xplico Evaluator. The tool was originally developed by request from one of our Evaluator clients.